Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region

BACKGROUND AND OBJECTIVES: Patients with diabetes mellitus inject insulin in different regions of the body. This study investigated the pharmacokinetic and pharmacodynamic properties of insulin degludec (IDeg), a new-generation once-daily basal insulin with an ultra-long duration of action, after su...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosek, Leszek, Coester, Hans-Veit, Roepstorff, Carsten, Thomsen, Henrik F., Kristensen, Niels R., Haahr, Hanne, Heise, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143594/
https://www.ncbi.nlm.nih.gov/pubmed/25124362
http://dx.doi.org/10.1007/s40261-014-0218-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143594/
https://www.ncbi.nlm.nih.gov/pubmed/25124362
http://dx.doi.org/10.1007/s40261-014-0218-x

Ejemplares similares